期刊文献+

糖尿病神经病变血清抗神经节苷脂抗体的观察 被引量:1

Measurement of anti-GS-ab in diabetic polyneuropathy patients
下载PDF
导出
摘要 目的 了解 2型糖尿病周围神经病变 (DPN)免疫功能状况。方法 受试者分为糖尿病无神经病变组 (DM组 )、DPN组、正常对照组 (N组 ) ,每组 30人。采用美国NicoletVikingⅣ型肌电图仪测定神经传导速度 ,固相酶免法测定各组血清抗神经节苷脂抗体 (anti GS ab)中的anti GS IgM ab、anti GS IgG ab ,同时观察部分细胞免疫及体液免疫及自身抗体指标。 结果 DPN组较其它两组体液免疫功能增高 ,IgM及自身抗体亦明显升高。anti GS ab水平明显高于其它两组 ,T淋巴细胞亚群CD4+ 、CD8+ 、IL 2值水平明显下降 ,IL 1β、TNF α显著增高。逐步回归分析 ,DPN组对anti GS ab有显著作用的因素依次为DPN的临床分级 (DPNC)、CIC、IL 1β。 结论 DPN患者体内确存在着免疫功能紊乱 ,了解DPN自身免疫状况 ,对DPN的早期诊断、病情判断及治疗具有重要意义。 Objective To investigate the relationship between anti-GS-ab and cell immune in diabetic polyneuropathy (DPN).Methods There were NIDDM patients without DPN(group DM), NIDDM with DPN(group DPN), health people(group N). Each group had 30 people. We used American Nicolet Viking Ⅳ electromyography to measure neural conduction rate and immobilized enzyme immunoassay to measure anti-GS IgM-ab 、 anti-GS IgG-ab, and to observe cellular immunity,humoral immunity,autoimmunity antibody.Results In group DPN, anti-GS-ab level was higher than that in group N and group DM,T-lymphocyte subgroup CD 4+ , CD 8+ ,IL-2 level obviously decreased, IL-1β,TNF-α significantly increased. Using regulation analysis, in sequence.Conclusion There are immune function chaos in patient's body.To understand autoimmunity condition is valuable to early diagnosis of DPN, judgment of clinical condition, remedy effect.
出处 《广西医学》 CAS 2004年第12期1760-1762,共3页 Guangxi Medical Journal
基金 广西自然科学基金资助项目 (98110 4 2 )
关键词 糖尿病神经病变 抗神经节苷脂抗体 T细胞亚群 白介素 肿瘤坏死因子 Diabetic polyneuropathy Anti-GS-ab T-lymphocyte subgroup Interlreukin Tumor necrosis factor
  • 相关文献

参考文献3

  • 1Feldman EL , Stevens MJ, Thomas PK, et al. A practical Twe-Step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy[J] . Diabetes Care , 1994,17(11) :10 281~10 289.
  • 2Schwerer B , Lassmann H , Kitz K, et al . Ganglioside GM1 , a molecular traget for immunological and toxic attackes : similarity of neuropathological lesions induced by ganglioside- antiserum and cholera toxin[J]. Acta Neuropathol(berl),1986,72(1):55.
  • 3Kroemer G, Wick G.The role of interleukin-2 in autoimmunity[J].Immunol Today, 1989, 10(7): 246.

同被引文献6

  • 1范冠杰(指导),孙素红,张宏生.糖尿病周围神经病变的临床疗效评定标准归类及分析[J].广西中医学院学报,2007,10(3):88-90. 被引量:26
  • 2Head KA. Peripheral neuropathy: pathogenic mechanism and alter- native therapies [J]. Altern Med Rev, 2006,11 (4) :294-329.
  • 3Hotta N, Kawamori R, Fukuda M, et al. Long-term clinical effects of epalrestat, an aldose reductase inhibitor, on progression of diabetic neuropathy and other mierovaseular complications: multivariate epide- miological analysis based on patient background factors and severity of diabetic neuropathy[J]. Diabet Med, 2012,29(12) :1529-1533.
  • 4Morano S, Tiberti C, Cristina G, et al. Autoimmune markers and neurological complications in non-insulin-dependent diabetes melli- tus[J]. Hum Immunol. 1999, 60(9) :848-854.
  • 5Boslem E, Meikle PJ, Biden TJ. Roles of ceramide and sphingolip- ids in pancreatic β-cell function and dysfunction[ J]. Islets, 2012, 4(3) :177-187.
  • 6曹平,刘雪辉,胡泉.依帕司他治疗糖尿病周围神经病变60例临床分析[J].中国老年学杂志,2011,31(18):3595-3596. 被引量:16

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部